Search hospitals > Montana > Billings
Billings Clinic Cancer Center
Claim this profileBillings, Montana 59101
Global Leader in Lung Cancer
Global Leader in Breast Cancer
Conducts research for Cancer
Conducts research for Breast cancer
Conducts research for Non-Small Cell Lung Cancer
406 reported clinical trials
3 medical researchers
Summary
Billings Clinic Cancer Center is a medical facility located in Billings, Montana. This center is recognized for care of Lung Cancer, Breast Cancer, Cancer, Breast cancer, Non-Small Cell Lung Cancer and other specialties. Billings Clinic Cancer Center is involved with conducting 406 clinical trials across 464 conditions. There are 3 research doctors associated with this hospital, such as John M. Schallenkamp, Benjamin T. Marchello, and Justin Bottsford Miller, MD.Area of expertise
1Lung Cancer
Global LeaderStage IV
Stage II
Stage I
2Breast Cancer
Global LeaderHER2 negative
ER positive
Stage IV
Top PIs
John M. SchallenkampBillings Clinic Cancer Center6 years of reported clinical research
Expert in Lung Cancer
Expert in Cancer
206 reported clinical trials
267 drugs studied
Benjamin T. MarchelloKalispell Regional Medical Center10 years of reported clinical research
Studies Breast Cancer
Studies Breast cancer
6 reported clinical trials
20 drugs studied
Justin Bottsford Miller, MDBillings Clinic Cancer Center6 years of reported clinical research
Studies Cervical Cancer
1 reported clinical trial
4 drugs studied
Clinical Trials running at Billings Clinic Cancer Center
Lung Cancer
Prostate Cancer
Breast Cancer
Bladder Cancer
Breast cancer
Pancreatic Cancer
Esophageal cancer
Ovarian Cancer
Cancer
Colorectal Cancer
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
Chemotherapy + Immunotherapy vs. Immunotherapy
for Advanced Lung Cancer
This phase III trial compares the effect of adding chemotherapy to immunotherapy (pembrolizumab) versus immunotherapy alone in treating patients with stage IIIB-IV lung cancer. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab and chemotherapy may help stabilize lung cancer.
Recruiting2 awards Phase 3
Osimertinib + Bevacizumab
for Lung Cancer
This phase III trial compares the effect of bevacizumab and osimertinib combination vs. osimertinib alone for the treatment of non-small cell lung cancer that has spread outside of the lungs (stage IIIB-IV) and has a change (mutation) in a gene called EGFR. The EGFR protein is involved in cell signaling pathways that control cell division and survival. Sometimes, mutations in the EGFR gene cause EGFR proteins to be made in higher than normal amounts on some types of cancer cells. This causes cancer cells to divide more rapidly. Osimertinib may stop the growth of tumor cells by blocking EGFR that is needed for cell growth in this type of cancer. Bevacizumab is in a class of medications called antiangiogenic agents. It works by stopping the formation of blood vessels that bring oxygen and nutrients to tumor. This may slow the growth and spread of tumor. Giving osimertinib with bevacizumab may control cancer for longer and help patients live longer as compared to osimertinib alone.
Recruiting2 awards Phase 331 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Billings Clinic Cancer Center?
Billings Clinic Cancer Center is a medical facility located in Billings, Montana. This center is recognized for care of Lung Cancer, Breast Cancer, Cancer, Breast cancer, Non-Small Cell Lung Cancer and other specialties. Billings Clinic Cancer Center is involved with conducting 406 clinical trials across 464 conditions. There are 3 research doctors associated with this hospital, such as John M. Schallenkamp, Benjamin T. Marchello, and Justin Bottsford Miller, MD.
Where is Billings Clinic Cancer Center located?
The Billings Clinic Cancer Center is located at 801 N 29th St, Billings, MT 59101.
Who should I call to ask about financial aid or insurance network?
**Billings Clinic Cancer Center Contact Information:**
- **Financial Assistance Department:**
- Mail: PO Box 35100, Billings, MT 59107-7000
- Phone: 406-238-2500 or 1-800-332-7156
- **Insurance Department:**
- Phone: 406-657-4676
- Email: roih@billingsclinic.org
Financial counselors are available to assist with insurance coverage and benefits determination. Further details on financial assistance and eligibility are available on the Billings Clinic website.
What insurance does Billings Clinic Cancer Center accept?
Billings Clinic Cancer Center accepts a wide range of insurance plans, including:
* Aetna
* Blue Cross Blue Shield
* Cigna
* First Choice Health
* Humana
* Medica
* Medicare
* MultiPlan
* PacificSource
* Premera Blue Cross
* Tricare
* UnitedHealthcare
However, it does not accept Health Sharing, Hospital Indemnity, Limited Benefit, MEC, Preventive Services, Short Term, or non-insurance plans. For the most current list of accepted insurance plans, please consult the Billings Clinic's official website or contact them directly.
What awards or recognition has Billings Clinic Cancer Center received?
Billings Clinic Cancer Center is accredited with Magnetâ„¢ designation by the American Nurses Credentialing Center, highlighting its excellence in nursing. It is renowned for its commitment to oncology research and clinical trials, ensuring advanced cancer care.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.